Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i> -Mutant Lung CancerAdam J. Schoenfeld, Helena A. Yu, Hira Rizvi et al.|Clinical Cancer Research|2020Cited by 381
The Genomic Landscape of <i>SMARCA4</i> Alterations and Associations with Outcomes in Patients with Lung CancerAdam J. Schoenfeld, Gregory J. Riely, Chai Bandlamudi et al.|Clinical Cancer Research|2020Cited by 281